Cardiovascular revascularization medicine Journal Citation Rate 2026

ISSN 1553-8389 eISSN 1878-0938 Elsevier BV NL

Q3 Quartile

About Cardiovascular revascularization medicine
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Cardiovascular revascularization medicine (CRM) is a peer-reviewed academic journal covering Acute Myocardial Infarction Research and Cardiac Imaging and Diagnostics, published by Elsevier BV in NL, catalogued under ISSN 1553-8389 (e-ISSN 1878-0938). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.09 (Q3 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$3230 USD).

Cardiovascular revascularization medicine Citation Rate 2026 — In Context

Cardiovascular revascularization medicine has a 2025 2-Year Citation Rate (OpenAlex) of 1.09, placing it in the Q3 quartile within the Acute Myocardial Infarction Research research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Cardiovascular revascularization medicine operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Cardiovascular revascularization medicine should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Cardiovascular revascularization medicine against similar journals in the field, use our journal comparison tool.

Submission Tips for Cardiovascular revascularization medicine
  • Budget $3230 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Acute Myocardial Infarction Research, Cardiac Imaging and Diagnostics, Cardiac Valve Diseases and Treatments. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Cardiovascular revascularization medicine Compares
Citation Rate vs Field Avg
-46%
Field avg: 2.02
APC vs Field Avg
+24%
Field avg: $2602

Compared against 12 journals in the same research areas.

ISSN (Print) 1553-8389
ISSN (Online) 1878-0938
Publisher Elsevier BV
Country Netherlands
APC / Cost $3230 USD
In-depth profile & metrics

Cardiovascular revascularization medicine is published by Elsevier BV and based in Netherlands. It runs on a subscription or hybrid model with an article-processing charge of USD 3230.

In our subject taxonomy, Cardiovascular revascularization medicine is classified under Acute Myocardial Infarction Research, Cardiac Imaging and Diagnostics, Cardiac Valve Diseases and Treatments and Coronary Interventions and Diagnostics.

Cardiovascular revascularization medicine is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 1.090.

Research Areas
Links
Frequently Asked Questions about Cardiovascular revascularization medicine

Cardiovascular revascularization medicine does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 1.090 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Cardiovascular revascularization medicine is not an open access journal.

The Article Processing Charge (APC) for Cardiovascular revascularization medicine is $3230 USD.

Cardiovascular revascularization medicine is published by Elsevier BV.

Cardiovascular revascularization medicine shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Cardiovascular revascularization medicine is 1553-8389. Its electronic ISSN (eISSN) is 1878-0938.

Cardiovascular revascularization medicine sits in the Q3 quartile based on its latest impact factor of 1.09, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
1.090
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 1.090 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S86061721

Get weekly updates for Acute Myocardial Infarction Research journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google